IDH2 and central nervous system cancer: Recent research has revealed lower overall levels of TILs in IDH-mutant gliomas than in IDH wild-type gliomas, with decreases in macrophages, T cells, B cells, and dendritic cells (51), consistent with our findings presented in Figure 5D and Figures S5A–C.